Medical Devices & Tech

Rockwell Medical Technologies

30142 Wixom Road
Wixom, MI 48393 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Hemodialysis concentrates and dialysis kits.

Management Robert L. Chioini, Founder, Chairman, Chief Executive Officer, President; Thomas E. Klema, Vice President, Chief Financial Officer and Secretary

Click here for Financial Data
Keywords: hemodialysis, dialysis, renal, kidney, kidney disease


Updated: Apr. 01, 2013


Rockwell manufactures and distributes hemodialysis concentrates, dialysis kits and ancillary products used in the dialysis process. Rockwell's products are used to cleanse the end stage renal disease ......view more

Products / Services

Rockwell provides a full-line of hemodialysis products. These include the proprietary Dri-Sate Dry Acid Concentrate Mixing System, RenalPure Liquid Acid Concentrate, SteriLyte Liquid Bicarbonate Conce......view more

Technology / Differentiation

Rockwell's proprietary iron replacement therapy delivers iron through a dialyzer and into the bloodstream without the need for needles or syringes. The product is administered three times a week, whil...view more

Market / Customers

There are an estimated 350,000 dialysis patients in the United States. The incidence of ESRD has increased approximately 6%-8% on average each year over the last decade, driven by an aging population......view more

Competitors / Substitutes / Alternatives

Rockwell Medical Technologies, Inc. is one of four major concentrate manufacturer/distributors in the U.S. Competitors include Mintech and Gambro Renal Products (now owned by DaVita Inc)....view more


Rockwell's SFP will deliver iron to the dialysis patient via the company's dialysate product line. Once approved by the FDA, the company believes its SFP will compete aggressively in the $300 million ...view more


Rockwell's SFP has completed an FDA-approved Phase-I and Phase-II Clinical trial. A Phase-III Clinical trial will be completed prior to market launch which is estimated to be first quarter 2008....view more